13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years

13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years - Adverse reaction of PCV13 with IIV in elderly

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032930

Enrollment

Registered

2018-06-08

Start date

2016-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumococcal Vaccine

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 13-valent pneumococcal conjugate vaccine

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Adverse reaction in 14 days	—

Countries

Japan

Contacts

Public ContactChigusa Iwasaki

RICERCA CLINICA Co.,Ltd Clinical support center

secretary@ricercaclinica.jp092-435-1150

Outcome results